Onfi FDA Approval History
FDA Approved: Yes (First approved October 21, 2011)
Brand name: Onfi
Generic name: clobazam
Dosage form: Tablets
Company: Lundbeck Inc.
Treatment for: Lennox-Gastaut Syndrome
Onfi (clobazam) is a benzodiazepine antiepileptic drug for the treatment of patients with Lennox-Gastaut syndrome (LGS).
Development Timeline for Onfi
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.